Legend Biotech Corporation (FRA:9LB)
16.60
-3.00 (-15.31%)
Last updated: Jul 28, 2026, 7:55 PM CET
Legend Biotech Revenue
Legend Biotech had revenue of $305.10M USD in the quarter ending March 31, 2026, with 56.46% growth. This brings the company's revenue in the last twelve months to $1.14B, up 56.38% year-over-year. In the year 2025, Legend Biotech had annual revenue of $1.03B with 64.02% growth.
Revenue (ttm)
$1.14B
Revenue Growth
+56.38%
P/S Ratio
3.32
Revenue / Employee
$367.35K
Employees
3,100
Market Cap
3.28B EUR
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.03B | 401.60M | 64.02% |
| Dec 31, 2024 | 627.30M | 342.20M | 120.03% |
| Dec 31, 2023 | 285.10M | 168.10M | 143.66% |
| Dec 31, 2022 | 117.01M | 48.18M | 70.00% |
| Dec 31, 2021 | 68.83M | -6.17M | -8.23% |
| Dec 31, 2020 | 75.00M | 15.02M | 25.04% |
| Dec 31, 2019 | 59.98M | 10.85M | 22.08% |
| Dec 31, 2018 | 49.13M | 25.54M | 108.24% |
| Dec 31, 2017 | 23.59M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Biotest GmbH & Co. KGaA | 648.90M |
| Novogenia AG | 54.30M |
| Paion AG | 14.81M |
| 2invest AG | 8.89M |
| MagForce AG | 1.08M |
| Biomark Diagnostics | 57.01K |
| co.don AG | 22.00K |
| bioXXmed AG | 16.73K |
Legend Biotech News
- 1 day ago - Legend Biotech falls -15.1% - TheFly
- 1 day ago - Legend Biotech falls -12.5% - TheFly
- 1 day ago - Legend Biotech price target lowered to $59 from $63 at RBC Capital - TheFly
- 1 day ago - Legend Biotech CEO Ying Huang steps down, Alan Bash named interim CEO - TheFly
- 1 day ago - Legend Biotech Announces CEO Transition - GlobeNewsWire
- 4 days ago - Legend Biotech downgraded to Neutral from Buy at UBS - TheFly
- 15 days ago - Legend Biotech resumed with a Neutral at JPMorgan - TheFly
- 21 days ago - Legend Biotech price target lowered to $63 from $64 at RBC Capital - TheFly